Product Information

VALSARTAN 320 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1750 per EA under NDC 00378581577. Its NADAC has been published 613 times since Feb 25, 2015.

FDA first approved this application on Jan 5, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALSARTAN 320 MG TABLET

valsartan
$0.1750per EA

Strength

320 mg/1

NDC

00378581577

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

VALSARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA090866

FDA Approved

1/5/2015

TE Code

AB

On Market Since

1/5/2015

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for VALSARTAN 320 MG TABLET has been published 613 times since Feb 25, 2015, and over the history we have for it it has declined 95.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1750 per EA
All-time high$4.1568 (Mar 11, 2015)
All-time low$0.1279 (Apr 18, 2018)
52-week high$0.1911
52-week low$0.1634
Median price$0.2786
Average price$0.3373
Largest weekly change+78.5% (Sep 19, 2018)
Weeks tracked613
Tracking sinceFeb 25, 2015

Price History

1W

+2.8%

1M

+7.1%

3M

+6.2%

6M

-4.5%

1Y

-8.2%

3Y

-21.0%

5Y

-51.5%

All

-95.8%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VALSARTAN 320 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN 320 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.1750 per EA (NDC 00378581577), effective Nov 18, 2026.

How has the price of VALSARTAN 320 MG TABLET changed over time?

Over the history we have for it, the NADAC for VALSARTAN 320 MG TABLET has declined 95.8%. It has been tracked across 613 weekly CMS publications since Feb 25, 2015.

What are the highest and lowest recorded NADAC prices for VALSARTAN 320 MG TABLET?

Since Feb 25, 2015, the NADAC for VALSARTAN 320 MG TABLET has ranged from a low of $0.1279 (Apr 18, 2018) to a high of $4.1568 (Mar 11, 2015), with a median of $0.2786 per EA.

Are there cheaper alternatives to VALSARTAN 320 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VALSARTAN 320 MG TABLET, is $0.1648 per EA — about 6% below VALSARTAN 320 MG TABLET.

Who manufactures VALSARTAN 320 MG TABLET?

VALSARTAN 320 MG TABLET (NDC 00378581577) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.